Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 49,803 | 31,081 | 1,204 | 139 | 298 |
| Cost of Goods | 274 | 616 | 85 | N/A | N/A |
| Gross Profit | 49,529 | 30,465 | 1,119 | 139 | 298 |
| Operating Expenses | 98,714 | 228,198 | 172,954 | 100,899 | 87,388 |
| Operating Income | -48,911 | -197,117 | -171,750 | -100,760 | -87,090 |
| Interest Expense | 8,339 | 15,579 | 13,101 | 2,780 | 802 |
| Other Income | 6,909 | 12,293 | 7,732 | 1,596 | 134 |
| Pre-tax Income | -50,341 | -200,403 | -177,119 | -101,944 | -87,758 |
| Net Income Continuous | -50,341 | -200,403 | -177,119 | -101,944 | -87,758 |
| Net Income | $-50,341 | $-200,403 | $-177,119 | $-101,944 | $-87,758 |
| EPS Basic Total Ops | -0.14 | -0.63 | -0.80 | -0.62 | -0.60 |
| EPS Basic Continuous Ops | -0.14 | -0.63 | -0.80 | -0.62 | -0.60 |
| EPS Diluted Total Ops | -0.14 | -0.63 | -0.80 | -0.62 | -0.60 |
| EPS Diluted Continuous Ops | -0.14 | -0.63 | -0.80 | -0.62 | -0.60 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.63 | -0.79 | -0.62 | -0.60 |
| EBITDA(a) | $-46,590 | $-194,738 | $-169,422 | $-99,592 | $-86,744 |